Legend Biotech (LEGN) Short-term Investments (2020 - 2024)
Legend Biotech (LEGN) posted Short-term Investments of -$149.8 million for Q3 2024, up 0.5% on a QoQ basis from -$150.6 million in Q2 2024, and down 180.63% year-over-year from $185.8 million in Q4 2023.
Legend Biotech (LEGN) Short-term Investments (2020 - 2024) Analysis & Trends
Legend Biotech's Short-term Investments history runs 5 years deep, the most recent figure standing at -$149.8 million for Q3 2024.
- Quarterly Short-term Investments fell 180.63% year-over-year to -$149.8 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was -$149.8 million (down 180.63% YoY) and the FY2023 annual result came in at $663000.0, up 100.23% from the prior year.
- Short-term Investments was -$149.8 million for Q3 2024 at Legend Biotech, up from -$150.6 million in the prior quarter.
- Across five years, Short-term Investments topped out at $185.8 million in Q3 2023 and bottomed at -$160.0 million in Q3 2022.
- A 5-year average of $14.8 million and a median of -$18.5 million in 2020 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2021 — Short-term Investments jumped 344.91% — and 2022, when it plunged 419.74%.
- Legend Biotech's Short-term Investments stood at -$22.7 million in 2020, then surged by 320.62% to $50.0 million in 2021, then surged by 270.91% to $185.6 million in 2022, then sank by 99.64% to $663000.0 in 2023, then sank by 22694.27% to -$149.8 million in 2024.
- Business Quant data shows LEGN's Short-term Investments at -$149.8 million in Q3 2024, -$150.6 million in Q2 2024, and $150.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -149.80 Mn |
| Jun 30, 2024 | -150.56 Mn |
| Mar 31, 2024 | 150.45 Mn |
| Dec 31, 2023 | 663,000.00 |
| Sep 30, 2023 | 185.79 Mn |
| Jun 30, 2023 | 185.76 Mn |
| Mar 31, 2023 | 185.71 Mn |
| Dec 31, 2022 | 185.60 Mn |
| Sep 30, 2022 | -160.00 Mn |
| Jun 30, 2022 | -100.00 Mn |
| Mar 31, 2022 | -100.00 Mn |
| Sep 30, 2021 | 50.04 Mn |
| Dec 31, 2020 | -22.68 Mn |
| Sep 30, 2020 | -20.43 Mn |
| Jun 30, 2020 | -18.50 Mn |